Exhibit 10.15
$5,000,000
MMCapSSM
CENTER BANCORP STATUTORY TRUST II
PLACEMENT AGREEMENT
New York, New York
December 12, 2003
SANDLER O'NEILL & PARTNERS, L.P.
919 Third Avenue
6th Floor
New York, New York 10022
Ladies and Gentlemen:
Center
Bancorp Statutory Trust II (the "Trust"), a statutory trust
organized under the Delaware Statutory Trust Act, 12 Del. C. ss. 3801 et
seq.
(the "Delaware Act"), and Center Bancorp,
Inc., a New Jersey
corporation (the
"Company" and together with the Trust, the
"Offerors"), confirm
their agreement
(the "Agreement") with Sandler O'Neill & Partners, L.P., as agent of the
Offerors (the "Placement Agent"), with respect to the issue and sale by
the
Trust and the placement by the Placement
Agent of 5,000
MMCapSSM (liquidation
amount of $1,000 per security) of the Trust (the "Capital Securities"). The
Capital Securities will be guaranteed by the Company
to the extent provided in
the Guarantee Agreement, to be dated as of the Closing Date (as defined in
Section 2(a) hereof) (the "Guarantee Agreement"), between the Company, as
guarantor, and Wilmington Trust Company,
as guarantee
trustee (the
"Guarantee
Trustee"), with respect to distributions and payments upon liquidation,
redemption and otherwise.
The
entire proceeds from the sale of the Capital Securities will be
combined with the entire proceeds from the sale by the
Trust to the Company of
its common securities (the "Common
Securities"),
and will be used by
the Trust
to purchase $5,155,000 aggregate principal amount of Floating Rate Junior
Subordinated Debt Securities due 2034 (the "Subordinated Debt Securities")
issued by the Company. The Capital Securities and the
Common Securities will be
issued pursuant to the Amended and Restated
Declaration of Trust, to be dated as
of the Closing Date (the "Declaration"), among the Company, as sponsor, the
Administrators named therein (the
"Administrators"),
Wilmington Trust
Company,
as institutional trustee (the "Institutional Trustee"), Wilmington Trust
Company, as Delaware trustee (the "Delaware
Trustee"),
and the holders,
from
time to time, of undivided beneficial interests in the assets
of the Trust. The
Subordinated Debt Securities will be issued pursuant to the Indenture,
to be
dated as of the Closing Date (the "Indenture"), between the Company and
Wilmington Trust Company, as indenture trustee (the
"Indenture Trustee").
The
Indenture, the Guarantee Agreement, the Declaration, this Agreement and the
Subscription Agreement (as defined in Section
2(a) hereof) are hereinafter
referred to collectively as the "Operative
Documents."
<PAGE>
SECTION 1.
Representations and Warranties.
(a) The
Trust and the
Company, jointly and severally, represent and
warrant to the Placement Agent and the Purchaser (as defined in Section 2(a)
hereof) of Capital Securities as of the date hereof
and as of the Closing Date,
and agree with the Placement Agent and the
Purchaser, as follows:
(i) Similar Offerings. Within a period of six months before or
after
the date hereof, the Offerors have not,
directly or
indirectly, solicited
any
offer to buy or offered to sell, and will
not, directly or
indirectly,
solicit
any offer to buy or offer to sell,
in the United States
or to any United States
citizen or resident, any security which is or would be
integrated with the sale
of the Capital Securities (including any securities of the same or a
similar
class as the Capital Securities) in a manner that would require the Capital
Securities to be registered under the Securities Act of 1933, as amended (the
"1933 Act").
(ii) Incorporated Documents. The documents of the Company filed
with
the Securities and Exchange Commission (the
"Commission") in accordance with the
Securities Exchange Act of 1934, as amended
(the "1934 Act"), from and including
the commencement of the fiscal year
covered by the Company's most recent Annual
Report on Form 10-K, at the time they were
or hereafter are filed by the Company
with the Commission (collectively, the "1934 Act Reports"),
complied and will
comply in all material respects with the requirements of the 1934 Act and the
rules and regulations of the Commission
thereunder (the "1934 Act Regulations"),
and, at the date of this Agreement and on the Closing Date,
do not and will not
include an untrue statement of a material fact or
omit to state a material fact
required to be stated therein or necessary to make the
statements therein,
in
the light of the circumstances under which they were made, not
misleading; and
other than such instruments, agreements, contracts and other documents as
are
filed as exhibits to the Company's Annual
Report on Form 10-K, Quarterly Reports
on Form 10-Q or Current Reports on Form 8-K, there are no instruments,
agreements, contracts or documents of a character described in Item 601 of
Regulation S-K promulgated by the Commission to
which the Company or any of its
subsidiaries is a party.
(iii) Independent
Accountants.
The accountants of the
Company who
certified the financial statements included in the 1934 Act Reports (the
"Independent Accountants") are independent
public accountants of the Company and
its subsidiaries within the meaning of the 1933 Act and the rules and
regulations of the Commission thereunder
(the "1933 Act Regulations").
(iv) Financial
Statements
and Information. The consolidated
historical financial statements of the Company, together with the related
schedules and notes, included in the 1934 Act Reports
present fairly, in all
material respects, the respective consolidated financial positions of the
Company and its consolidated subsidiaries
at the respective dates indicated, and
the consolidated statements of income, changes in
stockholders' equity and cash
flows of the Company and its consolidated subsidiaries for the respective
periods specified; said financial statements have been prepared in
conformity
with generally accepted accounting
principles in the
United States applied on a
consistent basis throughout the periods
involved, except as disclosed in the
notes to such financial statements;
the supporting
schedules, if any,
included
in the 1934 Act Reports present fairly, in all material respects, the
information required to be stated therein; and any pro forma financial
statements and the related notes thereto included in the 1934 Act Reports
present fairly the information shown therein, have been prepared in
accordance
with the Commission's rules and guidelines with respect
to pro forma financial
statements and have been properly compiled
on the bases described
therein, and
the assumptions used in the preparation thereof are reasonable and the
adjustments used therein are appropriate to
give effect to the transactions and
circumstances referred to therein.
2
<PAGE>
(v) No Material
Adverse Change.
Since the respective
dates as of
which information is given in the 1934
Act Reports, there has
not been (A) any
material adverse change in the condition,
financial, regulatory or otherwise, or
in the earnings, business affairs or business
prospects of the Trust
or of the
Company and its subsidiaries considered as one enterprise, whether or not
arising in the ordinary course of business
(a "Material Adverse
Effect") or (B)
any dividend or distribution of any kind declared, paid or made by the Company
on any class of its capital stock other
than regular quarterly
dividends on the
Company's common stock declared and paid
consistent with past practice.
(vi) Internal
Accounting
Controls. Each of the Company and its
subsidiaries maintain a system of internal
accounting
controls sufficient to
provide reasonable assurance that (i) transactions are executed in
accordance
with the management's general or specific
authorizations, (ii)
transactions are
recorded as necessary to permit preparation of financial statements in
conformity with generally accepted
accounting
principles and to
maintain asset
accountability, (iii) access to assets is
permitted only in accordance with the
management's general or specific authorization and (iv) the recorded
accountability for assets is compared
with the existing
assets at reasonable
intervals and appropriate action is taken
with respect to any differences.
(vii) Disclosure Controls. The Company has established and
maintains
disclosure controls and procedures (as such term is defined in Rule
13a-15(e)
and 15d-15(e) under the 1934 Act);
such disclosure
controls and
procedures (i)
are designed to ensure that material information relating to the Company,
including its consolidated subsidiaries, is made known to the Company's
Chief
Executive Officer and its Chief Financial Officer by others within those
entities, particularly during the periods in which the 1934 Act
Reports are
being prepared, (ii) have been evaluated for
effectiveness as of the end of the
annual or quarterly period reported to the
Commission and (iii) are effective to
perform the functions for which they were
established;
the Company's
auditors
and the Audit Committee of the Board of
Directors have been advised of: (A) any
significant deficiencies in the design or
operation of internal
controls which
could adversely affect the Company's
ability to record, process, summarize, and
report financial data and (B) any fraud,
whether or not material, that involves
management or other employees who have a role in the Company's internal
controls; any material weaknesses in
internal controls have been identified for
the Company's auditors; and since the date
of the most recent evaluation of such
disclosure controls and procedures,
there have been no
significant changes
in
internal controls or in other factors that
could significantly
affect internal
controls, including any corrective actions with regard to significant
deficiencies and material weaknesses.
(viii) Regulatory
Matters. Neither the Company nor any of its
subsidiaries is subject or is party to, or has
received any notice or advice
that any of them may become subject or
party to any
investigation with
respect
to, any corrective, suspension or cease-and-desist
order, agreement, consent
agreement, memorandum of understanding or
other regulatory
enforcement action,
proceeding or order with or by, or is a party to any commitment letter or
similar undertaking to, or is subject to any directive by, or has been a
recipient of any supervisory letter from, or has adopted any
board resolutions
at the request of, any Regulatory Agency (as defined below) that currently
relates to or restricts in any material
respect the conduct of their business or
that in any manner relates to their capital adequacy, credit policies,
management or business (each, a "Regulatory
Agreement"), nor has
the Company or
any of its subsidiaries been advised by any Regulatory Agency that it is
considering issuing or requesting any such
Regulatory
Agreement;
there is no
unresolved violation, criticism or exception by any Regulatory Agency with
respect to any report or statement
relating to any
examinations of the
Company
or any of its subsidiaries which, in the reasonable judgment
of the Company, is
expected to result in a Material Adverse Effect. As used herein, the term
"Regulatory Agency" means any federal or state agency charged with the
supervision or regulation of depositary
institutions
or holding
companies of
depositary institutions, or engaged in the insurance of
depositary institution
deposits, or any court, administrative agency or commission or other
governmental agency, authority or instrumentality having supervisory or
regulatory authority with respect to the
Company or any of its subsidiaries.
3
<PAGE>
(ix) No Undisclosed Liabilities. Neither the Company nor any of
its
subsidiaries has any material liability, whether known or unknown, whether
asserted or unasserted, whether absolute or contingent, whether accrued or
unaccrued, whether liquidated or
unliquidated, and whether due or to become due,
including any liability for taxes (and there is no past or present fact,
situation, circumstance, condition or other basis for any present or future
action, suit, proceeding, hearing, charge, complaint, claim or demand against
the Company or its subsidiaries
giving rise to any
such liability),
except (i)
for liabilities set forth in the financial
statements
referred to in
Section
1(a)(iv) above and (ii) normal fluctuations in the amount of the liabilities
referred to in clause (i) above
occurring in the
ordinary course of business of
the Company and all of its subsidiaries since the date of the most recent
balance sheet included in such financial
statements.
(x) Good Standing of the Company. The Company has been duly
organized and is validly existing as a corporation
in good standing
under the
laws of the State of New Jersey and has
full power and authority under such laws
to own, lease and operate its properties and to conduct its
business, to enter
into and perform its obligations under each
of the Operative
Documents to which
it is a party, and to issue the
Subordinated Debt Securities; and the Company is
duly registered as a bank holding
company under the Bank Holding Company Act of
1956, as amended.
(xi) Good Standing of the Subsidiaries. Each "significant
subsidiary" (as defined in Rule 1-02 of Regulation S-X) of the Company (a
"Significant Subsidiary") has been duly
organized and is validly existing as an
entity in good standing under the laws of the jurisdiction in which it is
chartered and has full power and
authority under such laws to own,
lease and
operate its properties and to conduct its
current and contemplated business; and
the deposit accounts of each of the
Company's subsidiary banks are insured up to
the applicable limits by the Bank Insurance Fund of the Federal Deposit
Insurance Corporation (the "FDIC") to the fullest extent
permitted by law
and
the rules and regulations of the FDIC, and no proceeding for
the revocation or
termination of such insurance is pending or, to the
knowledge of the
Company,
threatened.
4
<PAGE>
(xii) Foreign
Qualifications.
Each
of the Company and its
subsidiaries is duly qualified as a foreign entity to
transact business,
and
each is in good standing in each
jurisdiction
in which such
qualification
is
required, whether by reason of the
ownership or leasing of property or the
conduct of business, except where the failure to be so qualified would not
singularly, or in the aggregate, in the reasonable judgment of the
Company, be
expected to result in a Material Adverse
Effect.
(xiii) Capital Stock Duly Authorized and Validly Issued.
All of the
issued and outstanding capital stock of the
Company has been duly authorized and
validly issued and is fully paid and nonassessable; all of the issued and
outstanding capital stock of each subsidiary of the Company has been duly
authorized and validly issued, is fully paid and nonassessable and is owned by
the Company, directly or through subsidiaries, free and clear of any security
interest, mortgage, pledge, lien, encumbrance, claim or equitable right; and
none of the issued and outstanding capital stock of the Company or its
Significant Subsidiaries was issued in violation of any
preemptive or
similar
rights arising by operation of law, under the charter, by-laws or code of
regulations of the Company or any of its
Significant
Subsidiaries or under
any
agreement to which the Company or any of its Significant Subsidiaries is a
party.
(xiv) Good Standing of
the Trust. The Trust
has been duly
created
and is validly existing in good standing as
a statutory trust under the Delaware
Act with the power and authority to own property and to
conduct its business as
provided in the Declaration, to enter into
and perform its obligations under the
Operative Documents to which it is a party,
and to issue the Capital Securities
and the Common Securities; the Trust is not
a party to or otherwise bound by any
agreement other than the Operative Documents to which it is a party;
and the
Trust is, and will be, under current law,
classified
for United States
federal
income tax purposes as a grantor
trust and not as an
association
taxable as a
corporation.
(xv) Authorization of
Common Securities.
On the Closing Date,
the
Common Securities will have been duly authorized for issuance by the Trust
pursuant to the Declaration and, when duly issued and executed in
accordance
with the Declaration and delivered by the Trust to the
Company against payment
therefor in accordance with the
subscription agreement therefor, will be validly
issued and fully paid and nonassessable
undivided common
beneficial
ownership
interests in the assets of the Trust;
the issuance of the
Common Securities
is
not subject to preemptive or other similar
rights; and on the
Closing Date, all
of the issued and outstanding Common Securities of the Trust will be owned
directly by the Company, free and clear of any security interest, mortgage,
pledge, lien, encumbrance, claim or
equitable right.
(xvi) Authorization of Capital Securities. On the Closing Date, the
Capital Securities will have been duly authorized for issuance by the Trust
pursuant to the Declaration and, when duly
issued, executed and authenticated in
accordance with the Declaration and delivered by the Trust
against payment
therefor as provided herein and in the
Subscription
Agreement, will be
validly
issued and fully paid and nonassessable
undivided preferred beneficial ownership
interests in the assets of the Trust;
the issuance of the Capital
Securities
will not be subject to preemptive or other similar rights; and the Capital
Securities will be in the form contemplated
by, and entitled to the benefits of,
the Declaration.
5
<PAGE>
(xvii)
Authorization of this Agreement. This Agreement has been duly
authorized, executed and delivered by each
of the Offerors.
(xviii) Authorization
of Subscription
Agreement. The
Subscription
Agreement has been duly authorized, executed and delivered by each of the
Offerors, and assuming due authorization, execution and delivery of the
Subscription Agreement by the Purchaser, the Subscription Agreement will
constitute a valid, legal and binding agreement of each of the Offerors,
enforceable against each of the Offerors in
accordance with its terms, except to
the extent that enforceability may be limited by (a) bankruptcy, insolvency,
reorganization, moratorium, fraudulent conveyance or other
similar laws now or
hereafter in effect relating to creditors' rights generally and (b) general
principles of equity (regardless of whether
enforceability
is considered in a
proceeding at law or in equity)
(collectively, the "Enforceability Exceptions").
(xix) Authorization
of Declaration.
The Declaration has
been duly
authorized by the Company and, on the
Closing Date, will have been duly executed
and delivered by the Company and the Administrators, and assuming due
authorization, execution and delivery of the
Declaration by the
Institutional
Trustee and the Delaware Trustee, the
Declaration will constitute a valid, legal
and binding agreement of the Company, enforceable against the Company in
accordance with its terms, except to the extent that enforceability may be
limited by the Enforceability
Exceptions.
(xx) Authorization of Guarantee Agreement. The Guarantee Agreement
has been duly authorized by the Company
and, on the Closing Date, will have been
duly executed and delivered by the Company, and assuming due authorization,
execution and delivery of the Guarantee
Agreement by the Guarantee Trustee, the
Guarantee Agreement will constitute a valid,
legal and binding agreement of the
Company, enforceable against the Company in
accordance with its terms, except to
the extent that enforceability may be
limited by the Enforceability Exceptions.
(xxi) Authorization
of Indenture. The Indenture has been duly
authorized by the Company and, on the
Closing Date, will have been duly executed
and delivered by the Company,
and assuming due
authorization,
execution and
delivery of the Indenture by the Indenture Trustee, the Indenture will
constitute a valid, legal and binding agreement of the Company, enforceable
against the Company in accordance with its terms, except to the extent that
enforceability may be limited by the
Enforceability Exceptions.
(xxii)
Authorization of
Subordinated
Debt
Securities.
The
Subordinated Debt Securities have been duly authorized by the
Company; on the
Closing Date, the Subordinated Debt Securities will have been
duly executed by
the Company and, when authenticated in the manner
provided for in the Indenture
and delivered by the Company to the Trust against payment therefor as
contemplated in the subscription agreement therefor, will constitute valid,
legal and binding obligations of the
Company, enforceable against the Company in
accordance with their terms, except to the extent that
enforceability
may be
limited by the Enforceability Exceptions; the Subordinated Debt
Securities will
be in the form contemplated by, and entitled to
the benefits of, the Indenture;
and the Company has no present intention to exercise its option to defer
payments of interest on the Subordinated Debt Securities as provided in the
Indenture.
6
<PAGE>
(xxiii) Authorization of Administrators. Each of the Administrators
of the Trust is an officer or employee of the Company and has been duly
authorized by the Company to execute and
deliver the Declaration.
(xxiv) Not an Investment Company. Neither the Trust nor the
Company
is, and immediately following consummation of the transactions contemplated
hereby and the application of the net
proceeds therefrom
neither the Trust
nor
the Company will be, an "investment company" or an entity "controlled" by an
"investment company", in each case within the
meaning of Section
3(a) of the
Investment Company Act of 1940, as amended
(the "1940 Act"),
without regard to
Section 3(c) of the 1940 Act.
(xxv) Absence
of Defaults and Conflicts. The Trust is not in
violation of the trust certificate of the
Trust filed with the State of Delaware
(the "Trust Certificate") or the
Declaration, and neither the Company nor any of
its subsidiaries is in violation of its
charter, by-laws or code of regulations;
none of the Trust, the Company or any
subsidiary of the Company is in default in
the performance or observance of any obligation, agreement, covenant or
condition contained in any contract,
indenture, mortgage, deed of trust, loan or
credit agreement, note, lease or other agreement or
instrument to which it is a
party or by which it or any of them may be bound or to which any of its
properties or assets is subject
(collectively,
"Agreements and
Instruments"),
except for such defaults under Agreements and Instruments that, in the
reasonable judgment of the Company, are not expected to result in a
Material
Adverse Effect; and the execution, delivery and performance of the Operative
Documents by the Trust or the Company,
as the case may be,
the issuance,
sale
and delivery of the Capital Securities and
the Subordinated Debt Securities, the
consummation of the transactions
contemplated by the
Operative Documents,
and
compliance by the Trust and the Company with the terms of the Operative
Documents to which they are a party have
been duly authorized
by all necessary
corporate action on the part of the Company
and, on the Closing Date, will have
been duly authorized by all necessary
action on the part of the Trust and do not
and will not, whether with or without the
giving of notice or passage of time or
both, violate, conflict with or constitute a
breach of, or default or Repayment
Event (as defined below) under,
or result in the
creation or imposition of any,
security interest, mortgage, pledge, lien, charge, encumbrance, claim or
equitable right upon any properties or
assets of the Trust or the Company or any
of its subsidiaries pursuant to any of the
Agreements and Instruments, nor will
such action result in any violation of the
provisions of the charter, by-laws or
code of regulations of the Company or any
of its subsidiaries or the Declaration
or the Trust Certificate, or violation by
the Company or any of its subsidiaries
of any applicable law, statute, rule, regulation, judgment, order, writ or
decree of any government, government authority, agency (including, without
limitation, each applicable Regulatory Agency) or instrumentality or court,
domestic or foreign, having jurisdiction
over the Trust or the Company or any of
its subsidiaries or their respective properties or assets (collectively,
"Governmental Entities"). As used herein, a
"Repayment Event" means any event or
condition which gives the holder of any
note, debenture
or other evidence of
indebtedness (or any person acting on such
holder's behalf) the right to require
the repurchase, redemption or repayment of
all or a portion of such indebtedness
by the Trust or the Company or any of its
subsidiaries
prior to its
scheduled
maturity.
7
<PAGE>
(xxvi) Absence of Labor Dispute. No labor dispute with the
employees
of the Company or any of its subsidiaries exists or, to the knowledge of the
executive officers of the Company, is imminent, which, in the reasonable
judgment of the Company, is expected to
result in a Material Adverse Effect.
(xxvii) Absence
of Proceedings. There is no action, suit,
proceeding, inquiry or investigation before or brought by any Governmental
Entity, now pending, or, to the knowledge of the Trust or the Company,
threatened, against or affecting the Trust or the Company or any of its
subsidiaries, which, in the reasonable
judgment of the Trust
or the Company is
expected to result in a Material
Adverse Effect or materially and adversely
affect the consummation of the transactions contemplated by the Operative
Documents or the performance by the Trust or the Company of its obligations
hereunder or thereunder; and the aggregate of all pending
legal or governmental
proceedings to which the Trust or the Company
or any of its
subsidiaries is a
party or of which any of their respective properties or assets is the
subject,
including ordinary routine litigation
incidental to the
business, are not,
in
the reasonable judgment of the Company or the Trust, expected to result in a
Material Adverse Effect.
(xxviii) Absence
of Further Requirements. No filing with, or
authorization, approval, consent, license,
order, registration, qualification or
decree of, any Governmental Entity, other than those that have been
made or
obtained, is necessary or required for the
authorization, execution, delivery or
performance by the Trust or the Company of
their respective
obligations
under
the Operative Documents, the Subordinated Debt Securities or the Capital
Securities, as applicable, or the consummation by the Trust or the
Company of
the transactions contemplated by the
Operative Documents.
(xxix) Possession of
Licenses and Permits.
Each of the Trust,
the
Company and the subsidiaries of the Company possesses such permits, orders,
certificates, licenses, approvals, consents and other authorizations
(collectively, "Governmental Licenses") issued by the
appropriate Governmental
Entities necessary to conduct the business now
operated by it that is material
to the Trust or the Company and its
subsidiaries
considered as one
enterprise;
each of the Trust, the Company and the subsidiaries of the Company is in
compliance with the terms and conditions of
all of its
Governmental
Licenses,
except where the failure so to comply, in the reasonable judgment of the
Company, is not expected to, singularly or in the aggregate, have a Material
Adverse Effect; all of the Governmental
Licenses are valid and in full force and
effect, except when the invalidity of such
Governmental Licenses or the failure
of such Governmental Licenses to be in full force and
effect, in the reasonable
judgment of the Company, is not expected to have a Material
Adverse Effect; and
none of the Trust, the Company or any subsidiary of the Company has received
notice of any proceeding, and to the knowledge of the Trust,
the Company or any
subsidiary of the Company, there has been
no threatened proceeding, relating to
the revocation, termination, suspension or
modification of any such Governmental
Licenses which, singularly or in the aggregate,
in the reasonable
judgment of
the Company or the Trust, is expected to
result in a Material Adverse Effect.
8
<PAGE>
(xxx) Title to
Property. Each of the Trust, the Company and the
subsidiaries of the Company has good and marketable title to all of its
respective real and personal properties, in each case free and clear of all
liens, encumbrances and defects,
except such as, in the
reasonable judgment of
the Trust or the Company, singularly or in the aggregate, are not expected to
result in a Material Adverse Effect; and all of the leases and
subleases under
which the Trust, the Company or any subsidiary of
the Company holds
properties
are in full force and effect, except when the failure of such leases and
subleases to be in full force and
effect, in the reasonable judgment of the
Company, singularly or in the aggregate, is not expected to have a Material
Adverse Effect, and none of the Trust,
the Company or any
subsidiary
of the
Company has any notice of any claim of any
sort that has been asserted by anyone
adverse to the rights of the Trust, the
Company or any subsidiary of the Company
under any of the leases or subleases
under which the Trust,
the Company or any
subsidiary of the Company holds properties, or affecting or questioning the
rights of such entity to the continued possession of the leased or subleased
premises under any such lease or sublease, except when such claim, in the
reasonable judgment of the Company, singularly or in the aggregate, is not
expected to have a Material Adverse
Effect.
(xxxi) Stabilization.
The Company has not
taken and will not take,
directly or indirectly, any action designed to, or that might be reasonably
expected to, cause or result in
stabilization
or manipulation of the price of
the Capital Securities.
(xxxii) No General
Solicitation. Neither
the Trust or the
Company
nor any of their Affiliates (as defined in Rule 501(b)
under the 1933 Act)
or
any person acting on its or any of their
behalf (other than the Placement Agent,
as to whom the Offerors make no
representation)
has engaged or will
engage, in
connection with the offering of the Capital
Securities,
in any form of
general
solicitation or general advertising within the meaning of
Rule 502(c) under the
1933 Act.
(xxxiii) No
Directed Selling Efforts. Neither the Trust or the
Company nor any of their Affiliates or any person acting on
its or any of their
behalf (other than the Placement Agent, as to whom the Offerors make no
representation) has engaged or will engage in any directed selling efforts
within the meaning of Regulation S under the 1933 Act ("Regulation S") with
respect to the offering of the Capital
Securities.
(xxxiv) No
Registration. Subject
to compliance
by the Placement
Agent with the relevant provisions of Section 6 hereof,
it is not necessary
in
connection with the offer, sale and delivery of the Capital
Securities by the
Trust in the manner contemplated by this Agreement to register the Capital
Securities, the guarantee as described in the Guarantee Agreement or the
Subordinated Debt Securities under the 1933 Act or to qualify
the Declaration,
the Guarantee Agreement or the Indenture under
the Trust Indenture Act of 1939,
as amended.
(b) Any
certificate
signed by any Trustee of the Trust or any duly
authorized officer of the Company or any of
its subsidiaries
and delivered to
the Placement Agent or to counsel for the Placement Agent shall be deemed a
representation and warranty by the Trust or
the Company, as the
case may be, to
the Placement Agent as to the matters
covered thereby.
9
<PAGE>
SECTION 2.
Sale and Delivery through Placement Agent; Closing.
(a) The
Offerors propose to issue and sell the Capital Securities on
December 19, 2003 (or such other date
mutually agreed to by the Offerors and the
Placement Agent) (the "Closing Date") to
ALESCO Preferred
Funding II, Ltd.,
a
newly formed company with limited liability
incorporated
under the laws of
the
Cayman Islands (the "Purchaser"), pursuant to the terms of the Capital
Securities Subscription Agreement, entered into on the date hereof (the
"Subscription Agreement"), between the Offerors and the
Purchaser. In addition,
the Offerors agree that the Purchaser
shall be entitled to
the benefit of, and
to rely on, the provisions of this Agreement to the extent such provisions
address or relate to the Purchaser or the
Capital Securities to
be purchased by
the Purchaser.
(b) The
Offerors hereby grant
to the Placement Agent
the exclusive right
to arrange the placement of the Capital
Securities
with the Purchaser on
their
behalf. The Placement Agent accepts such right and agrees to use its best
efforts, on and prior to the Closing Date,
to effect such placement.
(c)
Deliveries of certificates for the Capital Securities shall be made
by
the Trust to or on behalf of the Purchaser
at the offices of Sidley Austin Brown
& Wood LLP in The City of New York,
and payment of the
purchase price for the
Capital Securities shall be made by the
Purchaser to the Trust by wire transfer
of immediately available funds to a bank designated by the Company
contemporaneous with closing on the Closing
Date.
Certificates for the Capital Securities in the aggregate
liquidation
amount thereof shall be registered in the
name of the Purchaser.
(d) As
compensation
to the Placement Agent for its placement of the
Capital Securities and in view of the fact
that the proceeds of the sale of the
Capital Securities will be used to
purchase the Subordinated Debt Securities of
the Company, the Company hereby agrees to pay on the Closing Date to the
Placement Agent in immediately available funds a commission of $25.00 per
Capital Security to be delivered by the
Trust hereunder on the Closing Date.
(e) In
performing its duties
under this Agreement,
the Placement
Agent
shall be entitled to rely upon any notice, signature or writing which the
Placement Agent shall in good faith believe to be genuine and to be
signed or
presented by a proper party or parties.
The Placement Agent may rely upon any
opinions or certificates or other documents delivered by the Offerors or
their
counsel or designees either to it or the
Purchaser. In
addition, in
connection
with the performance of its duties under
this Agreement,
the Placement
Agent
shall not be liable for any error of
judgment or any action
taken or omitted to
be taken unless it was grossly negligent or engaged in willful
misconduct
in
connection with such performance or non-performance. No provision of this
Agreement shall require the Placement
Agent to expend or
risk its own funds or
otherwise incur any financial liability on
behalf of the Purchaser in connection
with the performance of any of its duties
hereunder.
The Placement Agent
shall
be under no obligation to exercis